University of Washington, School of Dentistry, Regional Clinical Dental Research Center
Seattle, Washington, 98195, United States
NCT Number: NCT01823445
The purpose of this study is to demonstrate whether decay causing bacteria are reduced when adhesive xylitol disks are used intraorally three times a day for two weeks in adults with dry mouth.
Looking for future studies?
Notify Me21 year and older
All sexes
Interventional
Not applicable
Seattle, Washington, 98195, United States
Xylitol,an FDA approved sugar substitute, has been shown to reduce tooth decay. Patients who experience dry mouth may be more susceptible to dental decay because they lack the protection provided by an adequate flow of saliva. These patients are likely to have high levels of the decay causing bacteria, mutans streptococci.
The purpose of this research is to test the ability of a novel xylitol delivery vehicle to reduce mutans streptococci in patients with dry mouth over a two week period. The delivery vehicle is a slowly dissolving xylitol disk (lozenge) that adheres to soft tissues inside the mouth. Participants will place disks on both sides of the mouth three times a day.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Other names: XyliMelts
Time frame: One week
Change in mutans streptococci levels from Baseline to one week.
Time frame: Two weeks
Change in mutans streptococci levels from Baseline to two weeks.
Time frame: One week
Change in Groningen Radiotherapy-Induced Xerostomia (GRIX) quality of life questionnaire assessing xerostomia symptoms from Baseline to one week.
Time frame: Two weeks
Change in Groningen Radiotherapy-Induced Xerostomia (GRIX) quality of life questionnaire assessing xerostomia symptoms from Baseline to two weeks.
University of Washington
Other
XyliMelts Ability to Reduce Mutans Streptococci in Adults With the Perception of Dry Mouth
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03526315
Mutans Streptococci, Oral Health
Irbid, Jordan
View Trial DetailsNCT00966394
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorders
Jerusalem, Israel
View Trial DetailsNCT07394842
Carcinoma, Carcinoma, Squamous Cell
Cairo, Egypt
View Trial DetailsNCT02057510
Dental Disease, Head and Neck Cancer
Farmington, Connecticut, United States
View Trial Details